The markets opened lower with the Dow tumbling 109 points to 17,929 over strained Greek debt negotiations. Nasdaq dropped 22 points to 5,059.
On the upside
ITT Educational Services (NYSE: ESI) reported sharply higher first quarter earnings.
Sunesis Pharmaceuticals (Nasdaq: SNSS) reported additional upbeat data from the VALOR trial of vosaroxin and cytarabine to treat relapsed or refractory acute myeloid leukemia.
Shares of Sky-mobi (Nasdaq: MOBI) continued climbing.
On the downside
LeapFrog (NYSE: LF) widened fourth quarter losses more than expected as revenue fell.
The Food and Drug Administration suggested that AVEO (Nasdaq: AVEO) develop its biomarker assay before beginning a phase 3 study of tivozanib to treat low colorectal cancer.
Investors locked in profits on Axovant Sciences (NYSE: AXON).
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 fell 11 points to 2097. Bitcoin added $1 to $231.
Strained Greek talks send markets tumbling
June 12, 2015 at 10:44 AM EDT